Page last updated: 2024-10-24

celecoxib and Acute Febrile Neutrophilic Dermatosis

celecoxib has been researched along with Acute Febrile Neutrophilic Dermatosis in 4 studies

Research Excerpts

ExcerptRelevanceReference
"Sweet's syndrome (SS; acute febrile neutrophilic dermatosis) is a skin disorder characterized by acute tender erythematous plaques or nodules that may blister and ulcerate."1.37Sweet's syndrome associated with the intake of a selective cyclooxygenase-2 (COX-2) inhibitor. ( Lobo, I; Rosmaninho, A; Selores, M, 2011)
"Celecoxib is a new cyclo-oxygenase-2 inhibitor recently approved for arthritis."1.31Celecoxib-induced Sweet's syndrome. ( Berger, TG; Connolly, MK; Crowley, E; Fye, KH; LeBoit, PE, 2001)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oh, EH1
Shin, JM1
Hong, JH1
Kim, JS1
Ro, YS1
Ko, JY1
Rosmaninho, A1
Lobo, I1
Selores, M1
Fye, KH1
Crowley, E1
Berger, TG1
LeBoit, PE1
Connolly, MK1

Other Studies

4 other studies available for celecoxib and Acute Febrile Neutrophilic Dermatosis

ArticleYear
Drug-induced bullous Sweet's syndrome by celecoxib.
    The Journal of dermatology, 2016, Volume: 43, Issue:9

    Topics: Antirheumatic Agents; Arthralgia; Arthritis, Rheumatoid; Biopsy; Blister; Blood Sedimentation; C-Rea

2016
Sweet's syndrome associated with the intake of a selective cyclooxygenase-2 (COX-2) inhibitor.
    Cutaneous and ocular toxicology, 2011, Volume: 30, Issue:4

    Topics: Biopsy; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Glucocorticoids; Humans; Middle Aged; Predni

2011
Celecoxib-induced Sweet's syndrome.
    Journal of the American Academy of Dermatology, 2001, Volume: 45, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Drug Eruptions; Human

2001
Cutaneous drug reaction case reports: from the world literature.
    American journal of clinical dermatology, 2002, Volume: 3, Issue:1

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Bupropion; Celecoxib; Chlorquinaldol; Cytarabi

2002